Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.80 |
| ▸ | MEN1 | O00255 | 4/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.80 |
| ▸ | MAPT | P10636 | 4/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.80 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.80 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.80 |
| ▸ | RECQL | P46063 | 2/20 | 0.80 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.80 |
| ▸ | POLB | P06746 | 2/20 | 0.80 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.80 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.80 |
| ▸ | GAA | P10253 | 2/20 | 0.80 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.80 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.74 |
| ▸ | APP | P05067 | 1/20 | 0.74 |
| ▸ | XDH | P47989 | 1/20 | 0.66 |
| ▸ | CBS | P35520 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dihydrokaempferol SCHEMBL31026899 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL2036629 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL3437565 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL29454736 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL13354175 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL39319 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL3438673 | 1.00 | CYP3A4 (0.80) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Dihydrokaempferol SCHEMBL31547241 | 0.93 | MAPT (0.70) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL14461145 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 | |
| Pinobaksin SCHEMBL1045054 | 0.91 | MAPT (0.75) | CYP3A4MEN1KMT2AMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12454714-B2 | Monbretin A (MbA) synthesis using a heterologous nucleic acid(s) encoding A MbA pathway enzyme | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-28 | — | — | US | claimed |
| EP-4573202-A2 | FLAVONOID BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2025-06-25 | — | — | EP | claimed |
| CN-120019153-A | Biological production of flavonoids using microbial hosts | 德比生物技术公司 | 2025-05-16 | — | — | CN | claimed |
| WO-2024040211-A2 | FLAVONOID BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2024-02-22 | — | — | WO | claimed |
| EP-4323528-A1 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| CN-117413066-A | Biological production of flavonoids and anthocyanins using a microbial host | 德比生物技术公司 | 2024-01-16 | — | — | CN | claimed |
| US-20230000797-A1 | COMPOSITIONS AND METHODS FOR TREATING MOTOR DISORDERS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-01-05 | — | — | US | claimed |
| WO-2022221392-A1 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2022-10-20 | — | — | WO | claimed |
| US-20220333087-A1 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. | 2022-10-20 | — | — | US | claimed |
| US-11426366-B2 | Compositions and methods for treating motor disorders | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSSITY OF ARIZONA (US) | 2022-08-30 | — | — | US | claimed |
| CN-122038322-A | 4-Hydroxyphenylacetic acid 3-monooxygenase mutant and application thereof | 南京林业大学 | 2026-05-15 | — | — | CN | disclosed |
| EP-4702038-A1 | METHOD OF PRODUCING POLYPHENOLS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-20250331479-A1 | Anthocyanin-Free Broccoli | BEJO ZADEN BV (NL) | 2025-10-30 | — | — | US | disclosed |
| US-12454714-B2 | Monbretin A (MbA) synthesis using a heterologous nucleic acid(s) encoding A MbA pathway enzyme | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-10-28 | — | — | US | disclosed |
| EP-4627099-A2 | PROCESS FOR MAKING FLAVANONE DERIVATIVES | Firmenich SA (CH) | 2025-10-08 | — | — | EP | disclosed |
| CN-114657205-A | Application of OsF 3' H gene in resisting pathogens | 中国科学院分子植物科学卓越创新中心 | 2022-06-24 | — | — | CN | disclosed |
| CN-114480532-A | Application of strain CH18 in preparation of anthocyanin and other flavonoid compounds | 北京理工大学 | 2022-05-13 | — | — | CN | disclosed |
| CN-114364265-A | Flavanone derivatives and their use as sweetness enhancers | 弗门尼舍有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-114107329-A | Method for knocking out dihydroflavonol-4-reductase gene of tobacco to improve rutin content by using gene editing technology and application | 云南中烟工业有限责任公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-111254150-B | Ginkgo GbFLSa gene and expression protein and application thereof | 南京林业大学 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000797-A1 | COMPOSITIONS AND METHODS FOR TREATING MOTOR DISORDERS | SNCA, PARK7, COMT | CYP3A4 3627/4885MEN1 4514/4885KMT2A 55/4885 |
| US-11426366-B2 | Compositions and methods for treating motor disorders | COMT, SNCA, PARK7 | CYP3A4 3312/4885MEN1 4560/4885KMT2A 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.